Immunogenicity and risk factors associated with poor humoral immune response of SARS-CoV-2 vaccines in recipients of solid organ transplant: a systematic review and meta-analysis K Manothummetha, N Chuleerarux, A Sanguankeo, OS Kates, ... JAMA network open 5 (4), e226822-e226822, 2022 | 72 | 2022 |
Clinical outcomes in ocular pythiosis patients treated with a combination therapy protocol in Thailand: a prospective study N Permpalung, N Worasilchai, K Manothummetha, P Torvorapanit, ... Medical mycology 57 (8), 923-928, 2019 | 29 | 2019 |
Impact of SARS-CoV-2 infection on the profiles and responses of innate immune cells after recovery V Ruenjaiman, P Sodsai, P Kueanjinda, W Bunrasmee, S Klinchanhom, ... Journal of Microbiology, Immunology and Infection 55 (6), 993-1004, 2022 | 21 | 2022 |
Prevalence of Ocular Candidiasis and Candida Endophthalmitis in Patients With Candidemia: A Systematic Review and Meta-Analysis K Phongkhun, T Pothikamjorn, K Srisurapanont, K Manothummetha, ... Clinical Infectious Diseases 76 (10), 1738-1749, 2023 | 17 | 2023 |
Does post-transplant cytomegalovirus increase the risk of invasive aspergillosis in solid organ transplant recipients? A systematic review and meta-analysis N Chuleerarux, A Thongkam, K Manothummetha, S Nematollahi, ... Journal of Fungi 7 (5), 327, 2021 | 16 | 2021 |
Adjunctive antibacterial agents as a salvage therapy in relapsed vascular pythiosis patients N Susaengrat, P Torvorapanit, R Plongla, N Chuleerarux, ... International Journal of Infectious Diseases 88, 27-30, 2019 | 16 | 2019 |
Immunogenicity of SARS-CoV-2 vaccines in patients with multiple myeloma: a systematic review and meta-analysis N Chuleerarux, K Manothummetha, C Moonla, A Sanguankeo, OS Kates, ... Blood Advances 6 (24), 6198-6207, 2022 | 12 | 2022 |
In Vitro Susceptibility of Thai Pythium insidiosum Isolates to Antibacterial Agents N Worasilchai, A Chindamporn, R Plongla, P Torvorapanit, ... Antimicrobial agents and chemotherapy 64 (4), 10.1128/aac. 02099-19, 2020 | 11 | 2020 |
Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac R Nantanee, P Aikphaibul, P Jaru-Ampornpan, P Sodsai, O Himananto, ... Vaccine 40 (24), 3320-3329, 2022 | 10 | 2022 |
The association of cytomegalovirus infection and cytomegalovirus serostatus with invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients: a … N Chuleerarux, S Nematollahi, A Thongkam, MV Dioverti, ... Clinical Microbiology and Infection 28 (3), 332-344, 2022 | 9 | 2022 |
In vitro susceptibility of antibacterial agents against Thai Pythium insidiosum isolates N Worasilchai, A Chindamporn, R Plongla, P Torvorapanit, ... Antimicrob. Agents Chemother 64, e02099-19, 2020 | 8 | 2020 |
Clinical outcomes of radical surgery and antimicrobial agents in vascular pythiosis: a multicenter prospective study P Torvorapanit, N Chuleerarux, R Plongla, N Worasilchai, ... Journal of Fungi 7 (2), 114, 2021 | 6 | 2021 |
Ribavirin treatment for respiratory syncytial virus infection in patients with hematologic malignancy and hematopoietic stem cell transplant recipients: a systematic review and … K Manothummetha, T Mongkolkaew, P Tovichayathamrong, ... Clinical Microbiology and Infection, 2023 | 4 | 2023 |
Invasive Fungal Infections in Inpatient Solid Organ Transplant Recipients With COVID-19: A Multicenter Retrospective Cohort N Permpalung, TPY Chiang, K Manothummetha, D Ostrander, K Datta, ... Transplantation, 10.1097, 2024 | 1 | 2024 |
374. A Multicenter Open-Label Single-Arm Clinical Trial of Combination Therapy of Surgery, Itraconazole, Doxycycline, and Azithromycin for Vascular Pythiosis K Manothummetha, P Torvorapanit, N Susaengrat, N Worasilchai, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 444, 2023 | 1 | 2023 |
Needs assessment of a pythiosis continuing professional development program S Leksuwankun, R Plongla, N Eamrurksiri, P Torvorapanit, K Phongkhun, ... PLOS Neglected Tropical Diseases 18 (2), e0012004, 2024 | | 2024 |
Attenuated immunogenicity of SARS-CoV-2 vaccines and risk factors in stem cell transplant recipients: a meta-analysis T Meejun, K Srisurapanont, K Manothummetha, A Thongkam, N Mejun, ... Blood Advances, 2023 | | 2023 |
The lack of mortality benefit from ribavirin in patients with stem cell transplantation and hematologic malignancy with respiratory viral infections K Manothummetha, T Mongkolkaew, P Tovichayathamrong, ... SWISS MEDICAL WEEKLY 152, 33S-33S, 2022 | | 2022 |
Attenuated COVID-19 vaccine immunogenicity and risk factors in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis T Meejun, K Srirurapanot, K Manothummetha, A Thongkam, N Mejun, ... Swiss Medical Weekly, 35S-35S, 2022 | | 2022 |
The Association Between Cytomegalovirus And Invasive Fungal Infections in Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Systematic Review And Meta-Analysis N Chuleerarux, A Thongkam, S Nematollahi, V Dioverti-Prono, ... BONE MARROW TRANSPLANTATION 56 (SUPPL 1), 108-109, 2021 | | 2021 |